BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29065514)

  • 21. C-Abl as a modulator of p53.
    Levav-Cohen Y; Goldberg Z; Zuckerman V; Grossman T; Haupt S; Haupt Y
    Biochem Biophys Res Commun; 2005 Jun; 331(3):737-49. PubMed ID: 15865930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination.
    Lee MH; Lee SW; Lee EJ; Choi SJ; Chung SS; Lee JI; Cho JM; Seol JH; Baek SH; Kim KI; Chiba T; Tanaka K; Bang OS; Chung CH
    Nat Cell Biol; 2006 Dec; 8(12):1424-31. PubMed ID: 17086174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.
    Toledo F; Krummel KA; Lee CJ; Liu CW; Rodewald LW; Tang M; Wahl GM
    Cancer Cell; 2006 Apr; 9(4):273-85. PubMed ID: 16616333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
    Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
    Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations.
    Di Stefano V; Mattiussi M; Sacchi A; D'Orazi G
    FEBS Lett; 2005 Oct; 579(25):5473-80. PubMed ID: 16212962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
    Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
    Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcription factors that interact with p53 and Mdm2.
    Inoue K; Fry EA; Frazier DP
    Int J Cancer; 2016 Apr; 138(7):1577-85. PubMed ID: 26132471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 requires the stress sensor USF1 to direct appropriate cell fate decision.
    Bouafia A; Corre S; Gilot D; Mouchet N; Prince S; Galibert MD
    PLoS Genet; 2014; 10(5):e1004309. PubMed ID: 24831529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of Mdm2 and enhancement of cell survival by bFGF.
    Shaulian E; Resnitzky D; Shifman O; Blandino G; Amsterdam A; Yayon A; Oren M
    Oncogene; 1997 Nov; 15(22):2717-25. PubMed ID: 9400998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
    Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
    Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway.
    Xu L; Hu J; Zhao Y; Hu J; Xiao J; Wang Y; Ma D; Chen Y
    Apoptosis; 2012 Nov; 17(11):1235-45. PubMed ID: 22914926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stress.
    Chen Z; Cao Z; Zhang W; Gu M; Zhou ZD; Li B; Li J; Tan EK; Zeng L
    Hum Mol Genet; 2017 Nov; 26(22):4494-4505. PubMed ID: 28973420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidating the digital control mechanism for DNA damage repair with the p53-Mdm2 system: single cell data analysis and ensemble modelling.
    Ogunnaike BA
    J R Soc Interface; 2006 Feb; 3(6):175-84. PubMed ID: 16849229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of p53 stability by Mdm2.
    Kubbutat MH; Jones SN; Vousden KH
    Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
    Arriola EL; Lopez AR; Chresta CM
    Oncogene; 1999 Jan; 18(4):1081-91. PubMed ID: 10023685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest.
    Dubs-Poterszman MC; Tocque B; Wasylyk B
    Oncogene; 1995 Dec; 11(11):2445-9. PubMed ID: 8570197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.
    Stommel JM; Wahl GM
    EMBO J; 2004 Apr; 23(7):1547-56. PubMed ID: 15029243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.